The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(5-(Benzenesulfonamido)-1H-indol-1-yl)-N-methylpyridine-2-carboxamide ID: ALA4791071
PubChem CID: 162670394
Max Phase: Preclinical
Molecular Formula: C21H18N4O3S
Molecular Weight: 406.47
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CNC(=O)c1cc(-n2ccc3cc(NS(=O)(=O)c4ccccc4)ccc32)ccn1
Standard InChI: InChI=1S/C21H18N4O3S/c1-22-21(26)19-14-17(9-11-23-19)25-12-10-15-13-16(7-8-20(15)25)24-29(27,28)18-5-3-2-4-6-18/h2-14,24H,1H3,(H,22,26)
Standard InChI Key: LVLOSIZHMKLESY-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
27.3057 -4.1272 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.7226 -4.8412 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
28.1310 -4.1247 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.4344 -5.2566 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.1455 -4.8428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8567 -5.2557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8491 -3.6131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1414 -4.0244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5666 -4.0204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5643 -4.8412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3445 -5.0999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8306 -4.4364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3482 -3.7702 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.6018 -2.9919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4071 -2.8253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6660 -2.0455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1165 -1.4317 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.3089 -1.6028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0579 -2.3824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4700 -1.8782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0148 -2.4873 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.8188 -2.3200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7250 -1.0977 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.0172 -5.2562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3045 -4.8428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5937 -5.2560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5946 -6.0782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3120 -6.4855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0198 -6.0741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
2 4 1 0
4 5 1 0
5 6 2 0
6 10 1 0
9 7 1 0
7 8 2 0
8 5 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 9 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
13 14 1 0
16 20 1 0
20 21 1 0
21 22 1 0
20 23 2 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
2 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 406.47Molecular Weight (Monoisotopic): 406.1100AlogP: 3.19#Rotatable Bonds: 5Polar Surface Area: 93.09Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.78CX Basic pKa: 4.65CX LogP: 2.68CX LogD: 2.55Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.53Np Likeness Score: -1.69
References 1. Sbenati RM,Zaraei SO,El-Gamal MI,Anbar HS,Tarazi H,Zoghbor MM,Mohamood NA,Khakpour MM,Zaher DM,Omar HA,Alach NN,Shehata MK,El-Gamal R. (2021) Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells., 210 [PMID:33310290 ] [10.1016/j.ejmech.2020.113081 ]